An example of a two stage pathway is in North London where Srivastava et al. put in place a “NAFLD pathway” using FIB4 scoring and ELF test for stratification of patients with a clinical diagnosis of NAFLD or an abnormal ALT (22). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.